Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Wegovy Cut Heart Attack, Stroke Risks by 20%, Study Finds The findings are likely to further increase the use of Wegovy, Ozempic and similar drugs, despite growing concerns about severe stomach problems experienced by some users. November 15, 2023 Irvin Jackson Add Your Comments A new study suggests Wegovy, Ozempic and similar drugs may reduce the risks of heart attacks, strokes and death, providing positive findings about additional benefits associated with the diabetes and weight loss drugs, as other concerns continue to grow about the risk of severe stomach problems some users experience. In a report published in The New England Journal of Medicine on November 11, researchers evaluated the cardiovascular benefits associated with semaglutide-based drugs, which are sold by Novo Nordisk under the brand names Ozempic and Wegovy. The drugs are part of a new class of medications, known as glucagon like peptide-1 receptor agonists (GLP-1), which have become extremely popular in recent years, but also raise concerns about the potential long-term risks. Semaglutide was originally introduced under the brand name Ozempic, and approved by the FDA for treatment of people with Type 2 diabetes. However, amid aggressive marketing that highlighted the weight loss benefits, Ozempic has been increasingly prescribed as a diet drug, leading Novo Nordisk to introduce a higher dose version, known as Wegovy, which the FDA specifically approved for weight loss use. This new study was conducted by Novo Nordisk, and found that use of Wegovy was associated with a 20% drop in the risk of heart attacks and strokes, which the drug maker is certain to highlight in pushing for wider use of the medications. However, the findings also come amid increasing evidence that a larger-then-expected number of Ozempic and Wegovy users experience gastroparesis, which involves severe and long-term stomach problems that result from delayed gastric emptying caused by the drug. As a result of Novo Nordisk’s failure to sufficiently disclose the risk of long-term stomach problems, a number of former users are now pursuing Ozempic lawsuits and Wegovy lawsuits, each raising similar allegations that they could have avoided painful injuries if false and misleading information had not been provided for users and the medical community. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Wegovy and Ozempic Cardiovascular Benefits In this new report, Novo Nordisk researchers indicate they conducted a multicenter, double-blind, randomized placebo-controlled trial involving 17,604 patients. Subjects were 45 years old or older, and had preexisting heart disease and were overweight, with no history of diabetes. Half the patients received Wegovy, which is given in a higher dose than Ozempic, and half were given a placebo. Researchers looked for cardiovascular primary end points including death from heart problems, nonfatal heart attacks and non-fatal strokes. According to the findings, one of these events occurred in 6.5% of patients given Wegovy, compared to 8% among those given a placebo; a difference of 20%. “In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo in reducing the incidents of death from cardiovascular causes, nonfatal myocardial infarction, or nontafal stroke at a mean follow-up of 39.8 months. Expanded Ozempic, Wegovy Use Likely The findings come as the drugs have significantly increased in popularity due to their weight loss effects. Now, observers say, if the findings hold true, that popularity is likely to increase significantly. According to a recent Bloomberg News report, there are now more than 50 weight loss drugs in development by about 40 companies, with many involving new GLP-1 medications. The report indicates sales of weight loss drugs reached $6 billion this year, and could reach more than $100 billion by 2030. Earlier this month, the U.S. Food and Drug Administration announced approval for a new Eli Lilly drug, Zepbound (tirzepatide), which is a weight loss version of its diabetes drug, Mounjaro (tirzepatide), which belongs to the same class as Ozempic and Wegovy. Wegovy, Ozempic Stomach Problems Cause Concerns for Users While many overweight individuals are flocking to the new diet drugs, some experts have raised concerns about the lack of specific warnings for users and the medical community about the increased risk of severe stomach problems from Ozempic and Wegovy, which appear to be a direct side effect of the drugs’ primary mechanism of action, which delays gastric emptying. While this makes the user feel full longer and less hungry, the slow emptying can lead to stomach paralysis. In July, the American Society of Anesthesiologists (ASA) issued a warning about using Ozempic and Wegovy before surgery, indicating that the lack of gastric emptying linked to the drugs could put patients at risk of vomiting and aspiration while under the effects of anesthesia. Similar side effects are linked to Mounjaro, which could also pose a problem during surgical anesthesia. In 2017, researchers with the Mayo Clinic conducted a study involving a similar diabetes medication known as Victoza, which found that the drug caused significantly slower digestion in users, taking about 70 minutes for half the food they ate to leave their stomachs, compared to four minutes for people who did not take the drug. However, the study found that people’s bodies tended to adjust over time. In September, the U.S. Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages. The warning links Ozempic to a condition known as ileus, which can cause abdominal cramps, bloating, nausea, vomiting, constipation, difficulty passing gas and difficulty eating. Tags: Diabetes, Diabetes Drugs, Gastroparesis, Heart Attack, Heart Disease, Mounjaro, Novo Nordisk, Ozempic, Stomach Paralysis, Stroke, Wegovy, Weight Loss, Zepbound Find Out If You Qualify for Ozempic or Wegovy Compensation More Ozempic, Wegovy and Mounjaro Lawsuit Stories Ozempic Vision Risks Could Also Include Age-Related Macular Degeneration: Study June 23, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Saxenda, Wegovy Vision Loss Lawsuit Filed Over NAION Diagnosis June 13, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025) Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025) Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
Link Between Hair Relaxers and Cancer To Be Examined by Court During “Science Day” (Posted: 2 days ago) A federal judge has called for Science Day presentations to explain to the court the theories and evidence linking hair relaxer to increased cancer risks. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Cancer Lawsuits Continue To Be Filed as Lawyers Prepare First Cases for Trial (06/24/2025)Replacement Hair Relaxer Lawsuit To Be Selected for MDL Bellwether Pool (06/12/2025)Hair Relaxer Lawsuits and Talcum Powder Lawsuits Designated as New Mass Torts in Philadelphia (05/30/2025)
Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL (Posted: 2 days ago) A special mediator has been appointed to oversee negotiations between Johnson & Johnson and tens of thousands of women who say its talcum powder products caused them to develop reproductive system cancers. MORE ABOUT: TALCUM POWDER LAWSUITSTalcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial (07/01/2025)Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions (06/20/2025)Talc Safety To Be Subject of New Independent Scientific Expert Panel Led by FDA (05/22/2025)
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: 3 days ago) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)